Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 2/20 | 0.33 |
| ▸ | ADH1C | P00326 | 1/20 | 0.33 |
| ▸ | ADH1A | P07327 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8467901 | 1.00 | OPRM1 (0.33) | OPRM1ADH1CADH1AALDH1A1SLC18A3 | |
| SCHEMBL898580 | 1.00 | OPRM1 (0.33) | OPRM1ADH1CADH1AALDH1A1SLC18A3 | |
| SCHEMBL865400 | 1.00 | OPRM1 (0.33) | OPRM1ADH1CADH1AALDH1A1SLC18A3 | |
| SCHEMBL663435 | 1.00 | OPRM1 (0.33) | OPRM1ADH1CADH1AALDH1A1SLC18A3 | |
| SCHEMBL17429935 | 1.00 | OPRM1 (0.33) | OPRM1ADH1CADH1AALDH1A1SLC18A3 | |
| SCHEMBL21985216 | 0.96 | ADH1C (0.38) | OPRM1ADH1CADH1AALDH1A1 | |
| Hydrochloric Acid SCHEMBL6657602 | 0.93 | OPRM1 (0.32) | OPRM1ADH1CADH1A | |
| SCHEMBL11501607 | 0.92 | ADH1C (0.33) | ADH1CADH1AALDH1A1 | |
| SCHEMBL11510486 | 0.92 | ADH1C (0.33) | ADH1CADH1AALDH1A1 | |
| SCHEMBL11465502 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 233 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230174478-A1 | METHOD FOR PREPARING BRIVARACETAM AND INTERMEDIATE THEREOF | ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD (CN) | 2023-06-08 | — | — | US | claimed |
| US-7982064-B2 | Method for preparing ortho-substituted aminoferrocenes | BROCK UNIVERSITY (CA) | 2011-07-19 | — | — | US | claimed |
| US-20100137588-A1 | METHOD FOR PREPARING ORTHO-SUBSTITUTED AMINOFERROCENES | BROCK UNIVERSITY (CA) | 2010-06-03 | — | — | US | claimed |
| US-12583851-B2 | Heteroaryl-substituted pyrazine derivatives as pesticides | ELANCO ANIMAL HEALTH GMBH (DE) | 2026-03-24 | — | — | US | disclosed |
| US-12516021-B2 | Method for preparing brivaracetam and intermediate thereof | SHANGHAI SYNCORES TECHNOLOGIES INC. LTD. (CN) | 2026-01-06 | — | — | US | disclosed |
| CN-119661594-A | Fluorosulfonyl salt and preparation method and application thereof | 上海应用技术大学 | 2025-03-21 | — | — | CN | disclosed |
| CN-113582902-B | Preparation method of buvaracetam and intermediate thereof | 浙江华海药业股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| US-20240199604-A1 | SUPRAMOLECULAR POLYMER THERAPEUTICS AND DIAGNOSTICS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-06-20 | — | — | US | disclosed |
| US-20230242513-A1 | NOVEL HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES | ELANCO ANIMAL HEALTH GMBH (DE) | 2023-08-03 | — | — | US | disclosed |
| US-11690380-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | CORAL BAY II, LLC (US) | 2023-07-04 | — | — | US | disclosed |
| US-20230174478-A1 | METHOD FOR PREPARING BRIVARACETAM AND INTERMEDIATE THEREOF | ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD (CN) | 2023-06-08 | — | — | US | disclosed |
| US-20100305281-A1 | POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-12-02 | — | — | US | disclosed |
| US-20100137588-A1 | METHOD FOR PREPARING ORTHO-SUBSTITUTED AMINOFERROCENES | BROCK UNIVERSITY (CA) | 2010-06-03 | — | — | US | disclosed |
| US-5856540-A | 2,2'-disubtituted 1,1'-diphosphino-ferrocenes and 1',2-disubstituted 1-phosphino-ferrocenes, processes for preparing them, their use, and transition metal complexes comprising them | HOECHST AKTIENGESELLSCHAFT (DE) | 1999-01-05 | — | — | US | disclosed |
| US-4268455-A | Chelating tertiary amino metal amides | EXXON RESEARCH & ENGINEERING CO. (US) | 1981-05-19 | — | — | US | disclosed |
| US-4165330-A | REACTION OF ORGANOLITHIUM-CHELATE COMPLEX AND PROCHIRAL UNSATURATED CARBONYL COMPOUNDS | EXXON RESEARCH & ENGINEERING CO. (US) | 1979-08-21 | — | — | US | disclosed |
| US-4134938-A | ETHYLENE, STYRENE POLYMER-LITHIUM-CHELATING POLYAMINE COMPLEX | EXXON RESEARCH & ENGINEERING CO. (US) | 1979-01-16 | — | — | US | disclosed |
| US-4108921-A | Process for polymer lithiation in graft polymerization | EXXON RESEARCH & ENGINEERING CO. (US) | 1978-08-22 | — | — | US | disclosed |
| US-4107238-A | THERMOELASTOMERS, ISOBUTYLENE-CONJUGATED DIENE COPOLYMER, STYRENE | EXXON RESEARCH & ENGINEERING CO. (US) | 1978-08-15 | — | — | US | disclosed |
| US-4078019-A | Process for polymer lithiation in graft polymerization | EXXON RESEARCH & ENGINEERING CO. (US) | 1978-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199604-A1 | SUPRAMOLECULAR POLYMER THERAPEUTICS AND DIAGNOSTICS | MAPT, HTT, PSEN1 | OPRM1 4059/4885ADH1C 4628/4885ADH1A 4616/4885 |
| US-12583851-B2 | Heteroaryl-substituted pyrazine derivatives as pesticides | CBR3, CYCS, CWC15 | OPRM1 931/4885ADH1C 446/4885ADH1A 3014/4885 |
| US-20230242513-A1 | NOVEL HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES | DDT, PRXL2A, CAT | OPRM1 1972/4885ADH1C 2653/4885ADH1A 3240/4885 |
| US-20100137588-A1 | METHOD FOR PREPARING ORTHO-SUBSTITUTED AMINOFERROCENES | LPO, AOC1, AOC2 | OPRM1 2407/4885ADH1C 1960/4885ADH1A 1944/4885 |
| US-11690380-B2 | Antimicrobial guanidinium and thiouronium functionalized polymers | PUF60, CAPG, GMPS | OPRM1 2219/4885ADH1C 4389/4885ADH1A 4403/4885 |
| US-20100305281-A1 | POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF | PFAS, PAM, PCNA | OPRM1 3237/4885ADH1C 2432/4885ADH1A 2307/4885 |
| US-20230174478-A1 | METHOD FOR PREPARING BRIVARACETAM AND INTERMEDIATE THEREOF | BLVRB, GABBR2, CCKBR | OPRM1 822/4885ADH1C 748/4885ADH1A 813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.